• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胶质瘤中1q32扩增子的精细定位证实MDM4是主要的扩增靶点。

Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target.

作者信息

Riemenschneider Markus J, Knobbe Christiane B, Reifenberger Guido

机构信息

Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany.

出版信息

Int J Cancer. 2003 May 10;104(6):752-7. doi: 10.1002/ijc.11023.

DOI:10.1002/ijc.11023
PMID:12640683
Abstract

We previously reported on the amplification and overexpression of the mouse double minute 4 homolog gene (MDM4) from 1q32 in a subset of malignant gliomas (Riemenschneider et al., Cancer Res 1999;59:6091-6). More recently, amplification and overexpression of the neighboring contactin 2 gene (CNTN2) was reported in individual malignant gliomas without MDM4 amplification (Rickman et al., Cancer Res 2001;61:2162-8). To address the question of whether 1q32 carries 2 independent amplification targets or a common target other than MDM4 and CNTN2, we analyzed primary malignant gliomas for amplification and overexpression of 17 different genes from this region. Our results indicate a single region of amplification that comprises the genes MDM4, GAC1, PIK3C2B and PEPP3, with only MDM4 amplification being invariably associated with overexpression. CNTN2 was found to be coamplified with MDM4 in 3 malignant gliomas but overexpressed in only 1 of these tumors. No CNTN2 amplification was detected in any of 102 malignant gliomas without MDM4 amplification. Our data therefore corroborate the notion that MDM4 is the main amplification target on 1q32 in malignant gliomas. However, coamplification and overexpression of adjacent genes may provide an additional growth advantage in some malignant gliomas with MDM4 amplification.

摘要

我们之前报道过,在一部分恶性胶质瘤中,位于1q32的小鼠双微体4同源基因(MDM4)存在扩增和过表达(里门施奈德等人,《癌症研究》1999年;59:6091 - 6)。最近,有报道称在个别无MDM4扩增的恶性胶质瘤中,相邻的接触蛋白2基因(CNTN2)存在扩增和过表达(里克曼等人,《癌症研究》2001年;61:2162 - 8)。为了探讨1q32携带的是2个独立的扩增靶点,还是除MDM4和CNTN2之外的一个共同靶点,我们分析了原发性恶性胶质瘤中该区域17个不同基因的扩增和过表达情况。我们的结果表明,存在一个单一的扩增区域,该区域包含MDM4、GAC1、PIK3C2B和PEPP3基因,只有MDM4的扩增总是与过表达相关。在3例恶性胶质瘤中发现CNTN2与MDM4共同扩增,但其中只有1例肿瘤中CNTN2过表达。在102例无MDM4扩增的恶性胶质瘤中,未检测到任何CNTN2扩增。因此,我们的数据证实了MDM4是恶性胶质瘤中1q32上主要的扩增靶点这一观点。然而,相邻基因的共同扩增和过表达可能会在一些有MDM4扩增的恶性胶质瘤中提供额外的生长优势。

相似文献

1
Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target.恶性胶质瘤中1q32扩增子的精细定位证实MDM4是主要的扩增靶点。
Int J Cancer. 2003 May 10;104(6):752-7. doi: 10.1002/ijc.11023.
2
Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.在一部分无TP53突变或MDM2扩增的恶性胶质瘤中,1q32区域的MDM4(MDMX)基因发生扩增并过表达。
Cancer Res. 1999 Dec 15;59(24):6091-6.
3
Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.人类恶性胶质瘤中12q13 - q15扩增子的精细定位表明CDK4/SAS和MDM2是独立的扩增靶点。
Cancer Res. 1996 Nov 15;56(22):5141-5.
4
High-resolution array-based comparative genomic hybridization of bladder cancers identifies mouse double minute 4 (MDM4) as an amplification target exclusive of MDM2 and TP53.基于高分辨率芯片的膀胱癌比较基因组杂交研究确定小鼠双微体4(MDM4)为一个独立于MDM2和TP53的扩增靶点。
Clin Cancer Res. 2008 May 1;14(9):2527-34. doi: 10.1158/1078-0432.CCR-07-4129.
5
GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas.GAC1是位于染色体1q32.1带的富含亮氨酸重复序列超家族的新成员,在恶性胶质瘤中扩增并过度表达。
Oncogene. 1998 Jun 11;16(23):2997-3002. doi: 10.1038/sj.onc.1201828.
6
Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.在一部分无p53突变的人类恶性胶质瘤中,MDM2基因的扩增和过表达。
Cancer Res. 1993 Jun 15;53(12):2736-9.
7
Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue.用于检测从福尔马林固定石蜡包埋(FFPE)胶质瘤组织中提取的DNA中EGFR和MDM2基因扩增的差异PCR的可靠性。
J Neuropathol Exp Neurol. 1995 Jan;54(1):57-64. doi: 10.1097/00005072-199501000-00007.
8
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.早期生长反应基因EGR-1表现为一种抑制基因,在新鲜人脑胶质瘤中其表达下调,该下调与ARF/Mdm2无关,但与p53改变无关。
Clin Cancer Res. 2001 Sep;7(9):2788-96.
9
Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma.1q32.1 扩增细化了子宫内膜癌的分子分类。
Clin Cancer Res. 2017 Dec 1;23(23):7232-7241. doi: 10.1158/1078-0432.CCR-17-0566. Epub 2017 Sep 22.
10
Rare MDM4 gene amplification in colorectal cancer: The principle of a mutually exclusive relationship between MDM alteration and TP53 inactivation is not applicable.结直肠癌中罕见的 MDM4 基因扩增:MDM 改变与 TP53 失活之间相互排斥的原则不适用。
Oncol Rep. 2011 Jul;26(1):49-54. doi: 10.3892/or.2011.1270. Epub 2011 Apr 18.

引用本文的文献

1
TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms.三阴性乳腺癌对紫杉醇的反应模拟了干扰素反应,揭示了细胞周期相关的耐药机制。
Sci Rep. 2025 Feb 4;15(1):4294. doi: 10.1038/s41598-024-82218-9.
2
TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms.三阴性乳腺癌对紫杉醇的反应模拟了干扰素反应,揭示了与细胞周期相关的耐药机制。
bioRxiv. 2024 Jun 6:2024.06.04.596911. doi: 10.1101/2024.06.04.596911.
3
A comprehensive characterization of the transcriptome in enzalutamide resistance prostate cancer.
恩杂鲁胺耐药前列腺癌中转录组的全面表征
Ann Transl Med. 2021 Dec;9(24):1782. doi: 10.21037/atm-21-6191.
4
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma.转运蛋白TSPO在胶质母细胞瘤特征中的作用
Cancers (Basel). 2020 Oct 14;12(10):2973. doi: 10.3390/cancers12102973.
5
Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges.靶向MDMX用于癌症治疗:原理、策略与挑战
Front Oncol. 2020 Aug 5;10:1389. doi: 10.3389/fonc.2020.01389. eCollection 2020.
6
Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma.多个基因的拷贝数异常被鉴定为肝癌患者肝外无转移生存的预后标志物。
Curr Med Sci. 2019 Oct;39(5):759-765. doi: 10.1007/s11596-019-2103-6. Epub 2019 Oct 14.
7
A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.MDM4 3'UTR 内的一个遗传变异与 HPV16 阳性肿瘤和口咽癌的生存相关。
Mol Carcinog. 2019 Dec;58(12):2276-2285. doi: 10.1002/mc.23116. Epub 2019 Sep 12.
8
MDM4 contributes to the increased risk of glioma susceptibility in Han Chinese population.MDM4 导致汉族人群罹患神经胶质瘤的风险增加。
Sci Rep. 2018 Jul 23;8(1):11093. doi: 10.1038/s41598-018-29468-6.
9
Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles.基于肿瘤基因扩增图谱的成人原发性多形性胶质母细胞瘤患者的预后分层
Oncotarget. 2018 Jun 15;9(46):28083-28102. doi: 10.18632/oncotarget.25562.
10
Loss of digestive organ expansion factor ( reveals an essential role during murine embryonic development that is independent of p53.消化器官扩张因子的缺失揭示了其在小鼠胚胎发育过程中独立于p53的重要作用。
Oncotarget. 2017 Oct 26;8(61):103996-104006. doi: 10.18632/oncotarget.22087. eCollection 2017 Nov 28.